SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study

Yi-Ping Fang,1,2 Chih-Hung Chuang,3 Yi-Jhun Wu,1 Hsin-Che Lin,1 Yun-Chi Lu4 1School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, 2Department of Medical Research, Kaohsiung Medical University Hospital, 3Department of Medical Laboratory Science and Biotechnology, College of Health...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fang YP, Chuang CH, Wu YJ, Lin HC, Lu YC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/9cd75a128f0f4a81b14fd8182d6ba2c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9cd75a128f0f4a81b14fd8182d6ba2c6
record_format dspace
spelling oai:doaj.org-article:9cd75a128f0f4a81b14fd8182d6ba2c62021-12-02T02:21:27ZSN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study1178-2013https://doaj.org/article/9cd75a128f0f4a81b14fd8182d6ba2c62018-05-01T00:00:00Zhttps://www.dovepress.com/sn38-loaded-100-nm-targeted-liposomes-for-improving-poor-solubility--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yi-Ping Fang,1,2 Chih-Hung Chuang,3 Yi-Jhun Wu,1 Hsin-Che Lin,1 Yun-Chi Lu4 1School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, 2Department of Medical Research, Kaohsiung Medical University Hospital, 3Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, 4Graduate Institute of Medicine, Collage of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan Background: SN38 (7-ethyl-10-hydroxycamptothecin) is a camptothecin derivative acts against various tumors. However, SN38 is hydrolyzed in the physiological environment (pH 7.4), and this instability interferes with its potential therapeutic effect. Our objective was to investigate SN38-loaded liposomes to overcome the poor solubility of SN38 and its biodistribution, which further diminish its toxicity.Materials and methods: The sub-100 nm targeted liposomes was employed to deliver SN-38 and evaluate the characterization, release behaviors, cytotoxicity, in vivo pharmacokinetics and biochemical assay.Results: The SN38-loaded targeted liposomes consisted of small (100.49 nm) spherical nanoparticles with negative charge (-37.93 mV) and high entrapment efficiency (92.47%). The release behavior of the SN38-loaded targeted liposomes was fitted with Higuchi kinetics (R2=0.9860). Free SN38 presented initial burst release. The IC50 for the SN38-loaded targeted liposomes (0.11 µM) was significantly lower than for the SN38 solution (0.37 µM) in the MCF7 cell line (P<0.01). Confocal laser scanning microscopy also confirmed highly efficient accumulation in the MCF7 cells. Pharmacokinetics demonstrated that the SN38-loaded targeted liposomes had a slightly increased half-life and mean residence time and decreased area under the concentration–time curve and maximum concentration. The results suggested that retention was achieved while the exposure of SN38 was significantly decreased. A noninvasive in vivo imaging system also showed that the targeted liposomes selectively targeted MCF7 tumors. In vivo toxicity data demonstrated that the decrease in platelets was significantly improved by SN38-loaded targeted liposomes, and diarrhea was not observed in BALB/c mice.Conclusion: In summary, SN38-loaded targeted liposomes could be a good candidate for application in human breast cancer. Keywords: SN38, targeted liposome, pharmacokinetics, human breast cancer, toxicityFang YPChuang CHWu YJLin HCLu YCDove Medical PressarticleSN-38targeted liposomepharmacokineticshuman breast cancertoxicityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 2789-2802 (2018)
institution DOAJ
collection DOAJ
language EN
topic SN-38
targeted liposome
pharmacokinetics
human breast cancer
toxicity
Medicine (General)
R5-920
spellingShingle SN-38
targeted liposome
pharmacokinetics
human breast cancer
toxicity
Medicine (General)
R5-920
Fang YP
Chuang CH
Wu YJ
Lin HC
Lu YC
SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
description Yi-Ping Fang,1,2 Chih-Hung Chuang,3 Yi-Jhun Wu,1 Hsin-Che Lin,1 Yun-Chi Lu4 1School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, 2Department of Medical Research, Kaohsiung Medical University Hospital, 3Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, 4Graduate Institute of Medicine, Collage of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan Background: SN38 (7-ethyl-10-hydroxycamptothecin) is a camptothecin derivative acts against various tumors. However, SN38 is hydrolyzed in the physiological environment (pH 7.4), and this instability interferes with its potential therapeutic effect. Our objective was to investigate SN38-loaded liposomes to overcome the poor solubility of SN38 and its biodistribution, which further diminish its toxicity.Materials and methods: The sub-100 nm targeted liposomes was employed to deliver SN-38 and evaluate the characterization, release behaviors, cytotoxicity, in vivo pharmacokinetics and biochemical assay.Results: The SN38-loaded targeted liposomes consisted of small (100.49 nm) spherical nanoparticles with negative charge (-37.93 mV) and high entrapment efficiency (92.47%). The release behavior of the SN38-loaded targeted liposomes was fitted with Higuchi kinetics (R2=0.9860). Free SN38 presented initial burst release. The IC50 for the SN38-loaded targeted liposomes (0.11 µM) was significantly lower than for the SN38 solution (0.37 µM) in the MCF7 cell line (P<0.01). Confocal laser scanning microscopy also confirmed highly efficient accumulation in the MCF7 cells. Pharmacokinetics demonstrated that the SN38-loaded targeted liposomes had a slightly increased half-life and mean residence time and decreased area under the concentration–time curve and maximum concentration. The results suggested that retention was achieved while the exposure of SN38 was significantly decreased. A noninvasive in vivo imaging system also showed that the targeted liposomes selectively targeted MCF7 tumors. In vivo toxicity data demonstrated that the decrease in platelets was significantly improved by SN38-loaded targeted liposomes, and diarrhea was not observed in BALB/c mice.Conclusion: In summary, SN38-loaded targeted liposomes could be a good candidate for application in human breast cancer. Keywords: SN38, targeted liposome, pharmacokinetics, human breast cancer, toxicity
format article
author Fang YP
Chuang CH
Wu YJ
Lin HC
Lu YC
author_facet Fang YP
Chuang CH
Wu YJ
Lin HC
Lu YC
author_sort Fang YP
title SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
title_short SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
title_full SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
title_fullStr SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
title_full_unstemmed SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
title_sort sn38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/9cd75a128f0f4a81b14fd8182d6ba2c6
work_keys_str_mv AT fangyp sn38loadedlt100nmtargetedliposomesforimprovingpoorsolubilityandminimizingburstreleaseandtoxicityinvitroandinvivostudy
AT chuangch sn38loadedlt100nmtargetedliposomesforimprovingpoorsolubilityandminimizingburstreleaseandtoxicityinvitroandinvivostudy
AT wuyj sn38loadedlt100nmtargetedliposomesforimprovingpoorsolubilityandminimizingburstreleaseandtoxicityinvitroandinvivostudy
AT linhc sn38loadedlt100nmtargetedliposomesforimprovingpoorsolubilityandminimizingburstreleaseandtoxicityinvitroandinvivostudy
AT luyc sn38loadedlt100nmtargetedliposomesforimprovingpoorsolubilityandminimizingburstreleaseandtoxicityinvitroandinvivostudy
_version_ 1718402544492871680